BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34997406)

  • 21. Development of Vogt-Koyanagi-Harada Disease-like Uveitis during Treatment by Anti-programmed Death Ligand-1 Antibody for Non-small Cell Lung Cancer: A Case Report.
    Suwa S; Tomita R; Kataoka K; Ueno S
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1522-1526. PubMed ID: 33797309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma.
    Brambati M; Giuffrè C; Marchese A; Bandello F; Modorati GM; Miserocchi E
    Eur J Ophthalmol; 2022 Jan; 32(1):NP109-NP113. PubMed ID: 32998540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report.
    Koyama M; Nishijima E; Honda T; Gonmori-Ohta C; Sasamoto T; Tanaka K; Watanabe A; Nakano T; Akiyama M
    BMC Ophthalmol; 2024 Mar; 24(1):115. PubMed ID: 38481205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of pulse steroid treatment of ten days' long on the improvement of bacillary layer detachment in a patient with Vogt-Koyanagi Harada disease.
    Atas F; Kaya M; Saatci AO
    Rom J Ophthalmol; 2021; 65(2):183-186. PubMed ID: 34179585
    [No Abstract]   [Full Text] [Related]  

  • 25. Choroidal excavation in vogt-koyanagi-harada disease.
    Hashida N; Fok A; Nishida K
    Case Rep Ophthalmol; 2014 May; 5(2):222-5. PubMed ID: 25202266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VOGT-KOYANAGI-HARADA-LIKE UVEITIS FOLLOWED BY MELANOMA-ASSOCIATED RETINOPATHY WITH FOCAL CHORIORETINAL ATROPHY AND CHOROIDAL NEOVASCULARIZATION IN A PATIENT WITH METASTATIC CUTANEOUS MELANOMA.
    Ng CC; Alsberge JB; Qian Y; Freund KB; Cunningham ET
    Retin Cases Brief Rep; 2023 Jan; 17(1):18-22. PubMed ID: 33394953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of Nivolumab-Induced Vogt-Koyanagi-Harada Disease-Like Uveitis in a Patient Managed without Intravenous Methylprednisolone Therapy.
    Nagai R; Yamamoto A; Yoshida A; Mikawa A
    Case Rep Ophthalmol Med; 2023; 2023():9565205. PubMed ID: 36818144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bilateral Nivolumab-associated Vogt-Koyanagi-Harada-like Uveitis in a Patient with Metastatic Renal Cell Carcinoma].
    Czichos C; Wawrzynów B; Chamalis C; von Jagow B
    Klin Monbl Augenheilkd; 2021 Jun; 238(6):711-714. PubMed ID: 33395707
    [No Abstract]   [Full Text] [Related]  

  • 29. Annular choroidal detachment in a patient with Vogt-Koyanagi-Harada disease.
    Yamamoto N; Naito K
    Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):355-8. PubMed ID: 14963715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease presenting with unilateral exudative retinal detachment despite bilateral choroidal involvement.
    AlBloushi AF; Herbort CP; Abu El-Asrar AM
    Int Ophthalmol; 2021 Dec; 41(12):4187-4195. PubMed ID: 34346004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
    Manethova K; Ernest J; Hrevus M
    Eur J Ophthalmol; 2017 Jan; 27(1):e5-e8. PubMed ID: 28009404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Vogt-Koyanagi-Harada disease-like uveitis during treatment by anti-programmed death-1 antibody: a case report.
    Wang JN; Zhang Y; Huang CY; Li K; Yu XB
    BMC Ophthalmol; 2024 Jun; 24(1):240. PubMed ID: 38849786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choroidal Detachment following an Intravitreal Injection in a Patient with Vogt-Koyanagi- Harada Disease.
    Kumar N; Rana N; Bansal R
    Ocul Immunol Inflamm; 2021 Feb; 29(2):396-398. PubMed ID: 31664881
    [No Abstract]   [Full Text] [Related]  

  • 34. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
    Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
    Zhang C; Wang Y; Chen Y; Zhou H; Hong Q; Yu X; Ng TK; Cen LP
    BMC Ophthalmol; 2023 May; 23(1):199. PubMed ID: 37147563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical Coherence Tomography-Based Quantification of Photoreceptor Injury and Recovery in Vogt-Koyanagi-Harada Uveitis.
    Bae SS; Forooghian F
    Ocul Immunol Inflamm; 2017 Jun; 25(3):338-343. PubMed ID: 26903383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
    Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
    Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.
    Lee GE; Lee BW; Rao NA; Fawzi AA
    Ocul Immunol Inflamm; 2011 Feb; 19(1):42-7. PubMed ID: 21034311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis.
    Elhamaky TR
    Indian J Ophthalmol; 2022 Jul; 70(7):2465-2470. PubMed ID: 35791135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
    Yamaguchi Y; Otani T; Kishi S
    Am J Ophthalmol; 2007 Aug; 144(2):260-5. PubMed ID: 17533104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.